Home » Using PAT to Optimize Cell Culture for Monoclonal Antibody Development

Using PAT to Optimize Cell Culture for Monoclonal Antibody Development

Overview:

Ache Stokelman and colleagues on Amgen’s Global Process Science Team outline how they used BioProcessors Corp.’s SimCell platform to improve results.

Author: Ache Stokelman et al., Amgen Inc. and BioProcessors Corp. | File Type: PDF

Find more white papers on Automation Control

View all white papers »

More content on this topic:

  • Featured White Papers